Skip to Main Content

Author Details

Sichuan Xi
Center for Cancer Research, National Cancer Institute, National Institutes of Health
1994
62
32
PMIDPaper TitleJournal TitlePublished Year
36870293Cigarette Smoke Enhances the Malignant Phenotype of Esophageal Adenocarcinoma Cells by Disrupting a Repressive Regulatory Interaction Between miR-145 and LOXL2.Lab Invest2023
36870293Cigarette Smoke Enhances the Malignant Phenotype of Esophageal Adenocarcinoma Cells by Disrupting a Repressive Regulatory Interaction Between miR-145 and LOXL2.Lab Invest2023
36166308Liposomal UHRF1 siRNA shows lung fibrosis treatment potential through regulation of fibroblast activation.JCI Insight2022
36166308Liposomal UHRF1 siRNA shows lung fibrosis treatment potential through regulation of fibroblast activation.JCI Insight2022
36270982A TNFR1-UBCH10 axis drives lung squamous cell carcinoma dedifferentiation and metastasis through a cell-autonomous signaling loop.Cell Death Dis2022
36566325UHRF1-mediated ferroptosis promotes pulmonary fibrosis via epigenetic repression of GPX4 and FSP1 genes.Cell Death Dis2022
36566325UHRF1-mediated ferroptosis promotes pulmonary fibrosis via epigenetic repression of GPX4 and FSP1 genes.Cell Death Dis2022
36270982A TNFR1-UBCH10 axis drives lung squamous cell carcinoma dedifferentiation and metastasis through a cell-autonomous signaling loop.Cell Death Dis2022
32841701Scutellariabarbata D. Don extraction selectively targets stemness-prone NSCLC cells by attenuating SOX2/SMO/GLI1 network loop.J Ethnopharmacol2021
33487222Retraction notice to 'The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells' [EBioMedicine 35 (2018) 204-221].EBioMedicine2021
32927122UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma.J Thorac Oncol2021
32841701Scutellariabarbata D. Don extraction selectively targets stemness-prone NSCLC cells by attenuating SOX2/SMO/GLI1 network loop.J Ethnopharmacol2021
34790904Hookah Smoke Mediates Cancer-Associated Epigenomic and Transcriptomic Signatures in Human Respiratory Epithelial Cells.JTO Clin Res Rep2021
33487222Retraction notice to 'The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells' [EBioMedicine 35 (2018) 204-221].EBioMedicine2021
34790904Hookah Smoke Mediates Cancer-Associated Epigenomic and Transcriptomic Signatures in Human Respiratory Epithelial Cells.JTO Clin Res Rep2021
32927122UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma.J Thorac Oncol2021
31570787Bile acid-induced "Minority MOMP" promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1.Oncogene2020
31570787Bile acid-induced "Minority MOMP" promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1.Oncogene2020
33093558Author Correction: Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment.Sci Rep2020
33027592Aaptamine attenuates the proliferation and progression of non-small cell lung carcinoma.Pharm Biol2020
33027592Aaptamine attenuates the proliferation and progression of non-small cell lung carcinoma.Pharm Biol2020
33093558Author Correction: Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment.Sci Rep2020
29311298IKKα inactivation promotes Kras-initiated lung adenocarcinoma development through disrupting major redox regulatory pathways.Proc Natl Acad Sci U S A2018
29934340Induction of Thioredoxin-Interacting Protein by a Histone Deacetylase Inhibitor, Entinostat, Is Associated with DNA Damage and Apoptosis in Esophageal Adenocarcinoma.Mol Cancer Ther2018
30146342The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.EBioMedicine2018
29904125Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression.Oncogenesis2018
29311298IKKα inactivation promotes Kras-initiated lung adenocarcinoma development through disrupting major redox regulatory pathways.Proc Natl Acad Sci U S A2018
29546459Sodium selenite attenuates lung adenocarcinoma progression by repressing SOX2-mediated stemness.Cancer Chemother Pharmacol2018
29934340Induction of Thioredoxin-Interacting Protein by a Histone Deacetylase Inhibitor, Entinostat, Is Associated with DNA Damage and Apoptosis in Esophageal Adenocarcinoma.Mol Cancer Ther2018
30146342The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.EBioMedicine2018
29904125Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression.Oncogenesis2018
29546459Sodium selenite attenuates lung adenocarcinoma progression by repressing SOX2-mediated stemness.Cancer Chemother Pharmacol2018
27903989Repression of YAP by NCTD disrupts NSCLC progression.Oncotarget2017
28507311Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment.Sci Rep2017
29254145Bile acid and cigarette smoke enhance the aggressive phenotype of esophageal adenocarcinoma cells by downregulation of the mitochondrial uncoupling protein-2.Oncotarget2017
29109788Decrease in Lymphoid Specific Helicase and 5-hydroxymethylcytosine Is Associated with Metastasis and Genome Instability.Theranostics2017
27903989Repression of YAP by NCTD disrupts NSCLC progression.Oncotarget2017
29109788Decrease in Lymphoid Specific Helicase and 5-hydroxymethylcytosine Is Associated with Metastasis and Genome Instability.Theranostics2017
29254145Bile acid and cigarette smoke enhance the aggressive phenotype of esophageal adenocarcinoma cells by downregulation of the mitochondrial uncoupling protein-2.Oncotarget2017
28507311Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment.Sci Rep2017
27049829LGR5 expression is controled by IKKα in basal cell carcinoma through activating STAT3 signaling pathway.Oncotarget2016
27049829LGR5 expression is controled by IKKα in basal cell carcinoma through activating STAT3 signaling pathway.Oncotarget2016
25703328Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis.Oncogene2015
25703328Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis.Oncogene2015
24859470As a novel p53 direct target, bidirectional gene HspB2/αB-crystallin regulates the ROS level and Warburg effect.Biochim Biophys Acta2014
24859470As a novel p53 direct target, bidirectional gene HspB2/αB-crystallin regulates the ROS level and Warburg effect.Biochim Biophys Acta2014
24983628Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas.PLoS One2014
24983628Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas.PLoS One2014
23426183Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis.J Clin Invest2013
23597566The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas.Cancer Cell2013
  • 1 - 50 of 124

Recommended Authors

Wei Wang
Shanghai East Hospital, Tongji University School of Medicine
Career Start Year 2013
Number of shared co-authors 0
Zhixin Qiu
UPMC Hillman Cancer Center
Career Start Year 2012
Number of shared co-authors 0
Fei Li
Shanghai Pulmonary Hospital, Tongji University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Wei Zhang
Montefiore Medical Center
Career Start Year 2008
Number of shared co-authors 0
Xi Liu
College of Biology and Food, Shangqiu Normal University
Career Start Year 2007
Number of shared co-authors 1
Henry Yang
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Daniel Schramek
University of Toronto
Career Start Year 2005
Number of shared co-authors 0
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
Haitao Lan
Academy of Medical Sciences, Sichuan Provincial People's Hospital
Career Start Year 2003
Number of shared co-authors 0
Hae-Yun Jung
College of Life Science, CHA University
Career Start Year 2003
Number of shared co-authors 0
Yongmei Song
Shandong University of Traditional Chinese Medicine
Career Start Year 2003
Number of shared co-authors 7
Xin Yang
Peking University Cancer Hospital & Institute
Career Start Year 2002
Number of shared co-authors 0
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 4
Youn-Jae Kim
Research Institute, National Cancer Center
Career Start Year 2000
Number of shared co-authors 0
Aamer M Qazi
The University of Lahore
Career Start Year 1999
Number of shared co-authors 0
Kostyantyn Krysan
David Geffen School of Medicine at University of California at Los Angeles
Career Start Year 1999
Number of shared co-authors 0
Bing-Hung Chen
Kaohsiung Medical University
Career Start Year 1998
Number of shared co-authors 3
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 6
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Erxi Wu
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 1
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 0
Chang-Qi Zhu
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1996
Number of shared co-authors 0
Michael Peyton
Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center
Career Start Year 1994
Number of shared co-authors 1
David N Watkins
Research Institute in Oncology and Hematology
Career Start Year 1991
Number of shared co-authors 0
Enhua Wang
The First Hospital and College of Basic Medical Sciences, China Medical University
Career Start Year 1990
Number of shared co-authors 0
Qimin Zhan
Peking University Cancer Hospital
Career Start Year 1989
Number of shared co-authors 7
Charles M Rudin
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 2
David M Jablons
University of California, USA Cardiovascular Research Institute san francisco
Career Start Year 1981
Number of shared co-authors 1
Ming-Sound Tsao
University Health Network, University of Toronto
Career Start Year 1972
Number of shared co-authors 1
John D Minna
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1967
Number of shared co-authors 3

Collaborators

David S Schrump
Center for Cancer Research, National Cancer Institute
Co-authored papers 17
Jennifer R Grandis
University of California san francisco
Co-authored papers 15
Mary Zhang
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 11
Julie A Hong
National Cancer Institute, National Institutes of Health
Co-authored papers 9
Mahadev Rao
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences
Co-authored papers 6
Cuong Hoang-Vu
Center for Cancer Research, National Cancer Institute
Co-authored papers 5
Yuwei Zhang
Thoracic and GI Oncology Branch National Cancer Institute
Co-authored papers 4
Maocheng Yang
College of Basic Medicine, Army Medical University
Co-authored papers 3
Bin Yan
The University of Hong Kong
Co-authored papers 3
Xiaolin Wu
Leidos Biomedical Research Inc.
Co-authored papers 3
Yinling Hu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Feng Zhu
Basic Medical College, Qingdao University
Co-authored papers 3
Jami Willette-Brown
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Fang Liu
Chengdu Military General Hospital
Co-authored papers 3
Vivek Shukla
Chalmers University of Technology
Co-authored papers 3
Sandra Burkett
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Kaitlin C McLoughlin
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Young K Song
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Nasser K Altorki
New York-Presbyterian Hospital
Co-authored papers 2
Joanne Kamens
Co-authored papers 2
Shaojian Gao
Co-authored papers 2
Daniel E Johnson
University of California San Francisco
Co-authored papers 2
Zhonghe Sun
Jiangsu University
Co-authored papers 2
Sudheer Kumar Gara
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Thomas Ried
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Raphael Bueno
Co-authored papers 2
Patricia Fetsch
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Danny Wangsa
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Emily S Reardon
Center for Cancer Research National Cancer Institute, National Institutes of Health
Co-authored papers 2
Release 1.2